SGCB and chronic obstructive pulmonary disease: Taken together, four out seven studies demonstrated an improvement in exercise capacity in response to pharmacological interventions targeting the NO-sGC-cGMP pathway—particularly sildenafil—in patients with COPD-associated PH.